IPO of Oncimmune

Target
Company Name
Description Zeus Capital has advised Oncimmune plc on its £66m AIM IPO and £11m fundraising.
Global M&A Offices
Zeus (Global M&A United Kingdom)
Global M&A Advisory Advisor to the seller